Where does ViiV Healthcare Company rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ViiV Healthcare Company ranks #10,814 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ViiV Healthcare Company hold?

ViiV Healthcare Company holds 29 US utility patents granted between 2015 and 2024, spanning 6 technology areas.

What is ViiV Healthcare Company's Innovation Score?

ViiV Healthcare Company has an Innovation Score of 32.5 out of 100 (41st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does ViiV Healthcare Company focus on?

ViiV Healthcare Company's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 29 patents, ranking #678 of 6,058 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is ViiV Healthcare Company's patent grant rate increasing or decreasing?

ViiV Healthcare Company's recent grant velocity is -7% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for ViiV Healthcare Company's patents?

ViiV Healthcare Company's patents average 10.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ViiV Healthcare Company patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

ViiV Healthcare Company

USPTO PatentsView assignee record - 29 granted patents across 6 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Viiv ranks #10,814 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 6 technology areas.

#10,814
of 49,997 US assignees by volume: 41st percentile
by Innovation Score (32.5/100): 10.3
avg claims per patent: -7%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10814 · US Corporation #10,814 · 29 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 29 grants
UPPER-Q #10,814/49,997
PHOTO-FINISH Valo Health
CPC-NARROW A61P · 6 areas
INNOV-THIN 32.5/100
CLAIMS-PAR 10.3 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT -7% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Valo Health, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Viiv’s 32.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.7 pts (36%) Velocity 5.9 pts (18%) Breadth 8.7 pts (27%) Claim depth 6.2 pts (19%)

Qualcomm Incorporated · highest

85
Vitaworks IP · near

33
GiMer Medical · near

33
ViiV Healthcare · this assignee

33
Gibson Brands · near

32
Intercept Pharmaceut… · near

32
3D Lighting… · lowest

7

What this shows Viiv's Innovation Score is 32.5/100 (41st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Viiv?

Each dot is one of Viiv’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Viiv’s own 10.3 claims/patent is at or below the 15.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Viiv vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Viiv's grants concentrate

ViiV Healthcare Company is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (6 grants) versus a trough of 1 in 2018. By volume, Viiv sits between Vectura Delivery Devices Limited and World Centric.

Viiv's three-year grant acceleration

ViiV Healthcare Company shows 8 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Vectura Delivery…

29
Volvo Penta

29
Valo Health

29
Vector Launch

29
Vision Ease

29
Wellfine Silicone…

29
Wireless Advanced…

29
World Centric

29
Viiv Healthcare ◀

29

What this shows ViiV holds 29 patents at rank #10,814, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ViiV

By rank, the assignees closest to #10,814 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in ViiV's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for ViiV, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), ViiV ranks #678 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (33 here).

GiMer Medical Company Limited 33 Gibson Brands, Inc. 32 Vitaworks IP, LLC 33 Intercept Pharmaceuticals, Inc. 32

Viiv's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 41st percentile higher than 41% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

ViiV Healthcare Company patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	20.7%
2016	3	10.3%
2017	2	6.9%
2018	1	3.4%
2019	3	10.3%
2020	4	13.8%
2021	2	6.9%
2022	4	13.8%
2023	1	3.4%
2024	3	10.3%

Which technologies does ViiV Healthcare Company patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 29

C07D - Heterocyclic Compounds 21

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 20

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 5

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 2

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ViiV Healthcare Company's patent record in context - here's where to go next.

ViiV Healthcare Company's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #10,814 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ViiV Healthcare Company against Vectura Delivery Devices Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.